BioVie Inc. Deposit Liabilities, Accrued Interest
BioVie Inc. (BIVI) had Deposit Liabilities, Accrued Interest of $0 as of 2021-06-30, per its 10-K filed 2021-08-30.
Discontinued › Notes
us-gaap:DepositLiabilitiesAccruedInterest · last filed 2021-08-30
- 2021-06-30: Deposit Liabilities, Accrued Interest $0.00.
- 2021-03-31: Deposit Liabilities, Accrued Interest $0.00.
- 2020-06-30: Deposit Liabilities, Accrued Interest $48.41K.
| Period end | Deposit Liabilities, Accrued Interest |
|---|---|
| 2021-06-30 | $0.00 10-K · filed 2021-08-30 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 |
| 2020-06-30 | $48.41K 10-K · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |